Does tobacco use cause psychosis?

Cigarettes

Marcus Munafo appraises a recent systematic review and meta-analysis of prospective, case-control and cross-sectional studies, which finds that daily tobacco use is associated with an increased risk of psychosis and an earlier age at onset of psychotic illness.

[read the full story...]

Mood Matters: mood instability is common and associated with poor outcomes

shutterstock_275869019

Farhana Mann summarises an observational study of mood instability in people with mental illness, which explores its relationship with days spent in hospital, frequency of admissions, the likelihood of being sectioned and the chance of being prescribed antipsychotics and mood stabilisers.

[read the full story...]

Switching antipsychotics in schizophrenia: the OPTiMiSE RCT

shutterstock_93305014

Tracey Roberts summarises a recent paper that reviews the existing literature concerned with switching antipsychotics in patients with schizophrenia, and goes on to present the ongoing OPTiMiSE RCT in this field, which is due to be published in 2016.

[read the full story...]

What psychosocial factors promote and challenge mental health recovery?

CC Image courtesy of Andy Mitchell on Flickr

In this blog, Sarah Carr examines a systematic review into the psychosocial factors that help and hinder mental health recovery and discusses implications for policy.

[read the full story...]

Smoking cessation for people with severe mental illness

shutterstock_225156700

Sally Adams appraises and summarises the SCIMITAR pilot RCT, which investigates smoking cessation for people with severe mental ill health. The paper presents a highly promising bespoke intervention for smokers with bipolar disorder, psychosis or schizophrenia.

[read the full story...]

Smoking and risk of schizophrenia: new study finds a dose-response relationship

shutterstock_785405

Marcus Munafò looks at the mounting evidence about smoking and risk of schizophrenia, including a new case-control study that provides clear evidence of a prospective association between cigarette smoking and a subsequent diagnosis of schizophrenia.

[read the full story...]

Quetiapine for schizophrenia: more transparency needed in clinical trial reporting

shutterstock_122223547

Andrew Shepherd reports on a recent systematic review, meta-analysis and reappraisal of Quetiapine for schizophrenia, which concludes that Quetiapine IR has a small beneficial effect on psychotic symptoms, but also leads to weight gain and sedation.

[read the full story...]

CBTp and medication in the treatment of psychosis: summarising the best evidence

shutterstock_158430557

Clive Adams presents a summary of the latest evidence for CBTp and medication in the treatment of psychosis. This blog was published alongside Clive’s talk at the Understanding Psychosis and Schizophrenia conference in Bath on 11 June 2015

[read the full story...]

Placebo effect in psychiatry: what do we really know?

shutterstock_125031905

David Steele summarises a review of systematic reviews and meta-analyses, which looks at the mediators and moderators of the placebo effect in psychiatry.

[read the full story...]

Promoting smoking cessation in people with schizophrenia

shutterstock_276469196

Meg Fluharty summarises a recent clinical overview of smoking cessation in people with severe mental illness, which provides useful practical advice to clinicians who are trying to help service users with schizophrenia, psychosis and other conditions to quit smoking

[read the full story...]